| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |